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Abstract 
 
 
α-Crystallin is a member of the small heat shock protein (sHsp) family which exists as a 
multimer of αA- and αB-crystallin subunits in the ratio of 3:1 in the lens, where it was 
first identified. It is an intracellular molecular chaperone, capable of interacting with a 
multitude of target proteins to prevent their aggregation and precipitation. Initially 
considered to be solely a lens protein, individual αA- and αB-crystallin proteins have 
since been found in other organs with αB-crystallin in particular appearing to play a 
role in many neurodegenerative disorders (e.g. Alzheimer’s, Parkinson’s and 
Creutzfeldt-Jakob diseases). Due to the dynamic nature of α-crystallin oligomers and 
the propensity for subunit exchange, crystallisation of the protein has been impossible. 
As a result, the mechanisms by which α-crystallin functions remain elusive, as does a 
complete picture of the chaperone’s quaternary structure. 
 
In this study, recombinant human αA- and αB-crystallin were expressed and purified 
using conventional methods (Horwitz, J., Huang, Q-L., Ding, L. and Bova, M. P. (1998) 
Methods in Enzymology 290:363-383). A series of mutants of αA- and αB-crystallin 
were also constructed, with mutation sites concentrated in the C-terminal region of the 
protein and in particular the solvent-exposed and flexible C-terminal extension. This 
extension, which comprises 10 and 12 amino acids in human αA- and αB-crystallin, 
respectively, behaves in a similar manner to an unstructured peptide in solution. 
Previous NMR spectroscopic studies have indicated that it serves a crucial role in 
binding target proteins.  
C-Terminal extension mutants K175L, K174A/K175A, E164A/E165A, I159A/I161A 
and R163STOP (αB-crystallin) and S172L, T168L and R163STOP mutants  
 
xvi 
(αA-crystallin) were produced and purified in the same manner as for the wildtype 
proteins. The expected masses of mutants were confirmed by electrospray mass 
spectrometry (ESI-MS). Complete purification, however, of S172L and R163STOP αA-
crystallin was not achieved due to decreased aggregate size and excessive 
hydrophobicity, respectively. Purified wildtype and mutant proteins were structurally 
and functionally characterised using a variety of spectroscopic techniques. These 
included chaperone assays under both reduction and heat stress with insulin and βL-
crystallin as target proteins, respectively, intrinsic tryptophan fluorescence 
spectroscopy, far- and near-UV circular dichroism (CD) spectroscopy, thermostability 
studies, size-exclusion high-performance liquid chromatography (HPLC), mass 
spectrometry and nuclear magnetic resonance (NMR) spectroscopy. Many of the αB-
crystallin mutants purified successfully and provided insight into specific amino acid 
residues that are important for the chaperone action of the protein. These include the “I-
X-I motif” at the C-terminal end of the protein which is highly conserved throughout 
sHsps and is thought to be critical for oligomeric assembly. Mutation of both isoleucine 
residues in the αB-crystallin I-X-I motif to alanine resulted in a protein which formed 
larger oligomeric complexes than the wildtype protein. Truncation of the C-terminal 
extension of αB-crystallin resulted in a protein with severely impaired chaperone 
ability, increased tendency to aggregate and disrupted secondary, tertiary and quaternary 
structures. These results suggest that the polar and flexible C-terminal extension is also 
necessary for uniform oligomeric assembly as well as for the solubility of α-crystallin 
as a whole. Chaperone and thermostability studies on the double glutamic acid mutant 
(E164A/E165A) showed that these highly charged residues are critical to the solubility 
of αB-crystallin at higher temperature. Consistent with this, ion-pairs and the formation 
of salt bridges between charged amino acids on the surfaces of thermophilic proteins are 
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thought to be responsible for their increased thermostability. Recombinant human αA- 
and αB-crystallin were uniformly 15N-labelled for the purposes of 2D Nuclear Magnetic 
Resonance spectroscopy (NMR) studies. Measurement of 15N relaxation time constants 
(T1 and T2) and 15N Nuclear Overhauser Effects (NOEs) for both wildtype proteins and 
the K175L and I159/I161A mutants of αB-crystallin have provided detailed information 
on the relative flexibilities of residues in the protein's C-terminal extension. Substitution 
of a leucine residue for the C-terminal lysine (K175) increased extreme C-terminal 
mobility and substitution of the isoleucine pair of the I-X-I motif with alanine residues 
led to a disruption of flexibility throughout the C-terminal extension. 15N T1 and T2 and 
15N NOE values were also determined for 15N-labelled αA-crystallin in the presence of 
reduced α-lactalbumin in order to gain information on changes in the flexibility of the 
C-terminal extension upon chaperone interaction with a stressed target protein. Upon 
formation of a chaperone-target protein complex, the flexibilities of C-terminal residues 
of αA-crystallin were equalised across the extension indicating that the entire extension 
was involved in interaction with the target protein to some extent. 
The R120G αB-crystallin mutant, which is associated with desmin-related myopathy 
and cataract in humans was also expressed and purified for the purposes of further 
structural characterisation. Previous studies on this mutant have provided some 
ambiguous results with regard to its chaperone ability and general structural stability. It 
was found that in addition to being intrinsically unstable and susceptible to unfolding, 
R120G αB-crystallin underwent C-terminal proteolysis with time. Furthermore, R120G 
αB-crystallin exhibited marked substrate specificity and in fact, acted as an “anti-
chaperone” in the presence of reduced α-lactalbumin. Under these conditions, R120G 
αB-crystallin promoted the aggregation of the molten globule state of α-lactalbumin 
and co-precipitated with it out of solution. This study, therefore provided several 
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insights into structural and functional aspects of α-crystallin small heat shock chaperone 
proteins. 
 
 
